Private company

Ampio Pharmaceuticals, Inc.

Last updated Oct 16, 2026.

Overview

  • IndustryPharmaceutical Preparations
  • HeadquartersDE
  • Incorporated inDE2
  • Business address9800 Mount Pyramid Court, Suite 400, Englewood, Co 801122
  • Filer categoryNon-accelerated filer, Smaller reporting company2

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Financial statements

Net income345678-$8.6M in 2023−83% since 2017
-$75.0M-$50.0M-$25.0M0$25.0M$50.0M2017: -$51.9M-$51.9M20172018: $34.0M$34.0M20182019: -$13.6M-$13.6M20192020: -$15.9M-$15.9M2020+17%2021: -$17.1M-$17.1M2021+7%2022: -$16.3M-$16.3M2022−4%2023: -$8.6M-$8.6M2023−47%
Fiscal year20172018201920202021202220232024
Revenue
Cost of revenue
Research and development$6.8M4$12.6M5$9.2M6$11.9M7$8.9M8$2.4M8
Selling, general and admin
Operating income
Income tax$011
Net income-$51.9M3$34.0M4-$13.6M5-$15.9M6-$17.1M7-$16.3M8-$8.6M8
Earnings per share$0.464-$0.105-$0.096-$1.297-$21.688-$10.668
Earnings per share (diluted)-$0.124-$0.145-$0.096-$1.517-$29.328-$10.668

Compare Ampio Pharmaceuticals, Inc. with another company

Former names

  • Chay Enterprises, Inc.Oct 5, 2007 to Mar 17, 20102

Recent filings

  1. Jan 29, 20258-K
  2. Mar 27, 202410-K
  3. Mar 25, 20248-K
  4. Feb 28, 20248-K
  5. Feb 15, 20248-K
  6. Jan 25, 20248-K
  7. Jan 11, 20248-K
  8. Dec 21, 2023S-1
  9. Nov 14, 202310-Q
  10. Nov 2, 20238-K
  11. Oct 27, 20238-K
  12. Oct 6, 20238-K
  13. Oct 4, 20238-K
  14. Sep 22, 20238-K
  15. Aug 31, 20238-K

Every filing from the last three years, summarized. The full record is on SEC EDGAR.1